Tumor recurrence also showed a strong association with biomarker expression (P < 0.001); 19 of 21 recurrent cases displayed concurrent high PD-L1 and LC3B expression, while two cases exhibited high PD-L1 with low LC3B expression. This evidence concerns the gene MAP1LC3B and neoplasm.